11:20 AM
 | 
Nov 19, 2018
 |  BC Extra  |  Financial News

NASH company Genfit planning U.S. listing

As it prepares for a readout from a Phase III study of its lead candidate to treat non-alcoholic steatohepatitis, French bellwether Genfit S.A. (Euronext:GNFT) intends to conduct a listing on a U.S. exchange.

Genfit said Monday it had filed a confidential draft F-1 with the SEC seeking to list ADSs. The company also intends to conduct a concurrent ex-U.S. private placement, primarily in Europe. Financial terms have yet to...

Read the full 325 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >